PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Assessment of regulatory needs (ARN).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.

A summary of all the substance-specific activities can be found under ‘Details’ for each entry.

Filter the list
Latest update:
Process:

The List does not contain any Substances.
Data generation and assessment ARN Regulatory risk management
 
Lithium nitrate 232-218-9 7790-69-4 - - - - 1 - - - - Details
Lithium perchlorate 232-237-2 7791-03-9 - - - - 1 - - - - Details
Lithium phosphorodifluoridate 643-080-8 24389-25-1 - - 1 - 1 - - - - Details
Lithium salicylate 209-011-7 552-38-5 - - - - 1 - - - - Details
lithium sodium 2-amino-4-{[4-(cyanoazanidyl)-6-[(3-sulfonatophenyl)amino]-1,3,5-triazin-2-yl]amino}-5-(2-{4-[2-(sulfonatooxy)ethanesulfonyl]phenyl}diazen-1-yl)benzene-1-sulfonate 413-090-5 - - - 1 - - - - - - Details
Lithium sodium 3-amino-10-{4-(10-amino-6,13-dichloro-4,11-disulfonatobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-3-ylamino)-6-[methyl(2-sulfonato-ethyl)amino]-1,3,5-triazin-2-ylamino}-6,13-dichlorobenzo[5,6][1,4]oxazino[2,3-b]phenoxazine-4,11-disulfonate
DIRECT BLUE FC 57087
418-870-9 154212-58-5 - - - - - 1 - - - Details
Lithium sodium hydrogen 4-amino-6-(5-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate
REACTIVE BLUE FC 05 717
401-560-2 108624-00-6 - - - - 1 - - - - Details
Lithium stearate 224-772-5 4485-12-5 - - 1 - - - - - - Details
Lithium sulfate monohydrate 600-157-0 10102-25-7 - - - - 1 - - - - Details
Lithium sulphate 233-820-4 10377-48-7 - - - - 1 - - - - Details
Lithium sulphide, anhydrous 235-228-1 12136-58-2 - - - - 1 - - - - Details
Lithium tetrafluoroborate, anhydrous 238-178-9 14283-07-9 - - 1 - - - - - - Details
Lithium, sodium 2-(4-chloro-6-cyanoamino-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(2-methoxy-5-(sulfatoethanesulfonyl)phenylazo)naphthalene-1,7-disulfonate 440-050-4 - - - 1 - 1 - - - - Details
Lithium-2-methoxyethoxide 460-000-5 20246-63-3 - - - - 1 - - - - Details
long chain alkyl thio carbamide metal complex 457-320-2 - - - 2 - 1 - - - - Details
Long-chain perfluorocarboxylic acids, their salts and related compounds
Long-chain PFCAs and their salts are a homologous series of substances with the molecular formula of CnF2n+1CO2H (where 8 ≤ n ≤ 20). Related compounds are viewed as any substance that is a precursor and may degrade or transform to long-chain PFCAs, where the perfluorinated alkyl moiety has the formula CnF2n+1 (where 8 ≤ n ≤ 20) and is directly bonded to any chemical moiety other than a fluorine, chlorine or bromine atom
- - - - - - - - - - - Details
Lubricating oils, used 274-635-9 70514-12-4 - - 4 - - - - - - Details
Luganil Schwarz LD 6253 470-210-9 - - - - - 1 - - - - Details
Lysine hydrochloride 211-519-9 657-27-2 - - 1 - - - - - - Details
m,α-dimethylstyrene 214-394-9 1124-20-5 - - - - 1 - - - - Details
m-(2,3-epoxypropoxy)-N,N-bis(2,3-epoxypropyl)aniline 275-662-9 71604-74-5 - - 3 - 1 - - - - Details
m-bis(1-methylvinyl)benzene 223-146-9 3748-13-8 - - - - 1 - - - - Details
m-bis(2,3-epoxypropoxy)benzene 202-987-5 101-90-6 - - - - 1 1 - - - Details
m-cresol 203-577-9 108-39-4 - - 2 - - - - - - Details
m-cymene 208-617-9 535-77-3 - - - - 1 - - - - Details

Export search results to: